Evanthia Galanis

3 ta ish

Mayo Clinic

1. Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

   Evanthia Galanis, Lynn C. Hartmann, William A. Cliby +17

   MaqolaOAOchiq kirish20103 iqtibos

   ABIABI:AkademIndex/2026.other.082775

2. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

   Patrick Y. Wen, David R. Macdonald, David A. Reardon +16

   Maqola20103 iqtibos

   ABIABI:AkademIndex/2026.other.357042

3. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

   Ta‐Chiang Liu, Evanthia Galanis, David H. Kirn

   Sharh maqola20072 iqtibos

   ABIABI:AkademIndex/2026.other.047581